BIONTECH (BNTX) CEO Ugur Sahin Sells $8.4M in Shares
Two open-market sales on September 11 and 14 cut the founder-CEO's directly held stake to 602,209 ordinary shares.
BioNTech SE (BNTX) chief executive and co-founder Ugur Sahin sold about $8.44 million of ordinary shares in two open-market transactions this month, according to Form 4 filings with the Securities and Exchange Commission. Sahin is listed both as Chief Executive Officer and as a 10% owner of the German vaccine and oncology company.
